Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage

Abstract

Hypoalbuminaemia may serve as severity marker of epithelial-endothelial damage in patients with COVID-19. There are clues that pulmonary capillary leak syndrome plays a key role in the pathogenesis of COVID-19 and might be a potential therapeutic target.